Proxim Diagnostics has developed an advanced handheld immunodiagnostic device designed for point-of-care testing, particularly for critical laboratory tests that can be performed using whole blood. This innovative system is engineered to deliver high sensitivity and precision, providing essential diagnostic information to healthcare professionals at the moment it is needed. The device is battery-operated and features a user-friendly touch-screen interface, along with multiple connectivity options including wireless, Ethernet, and USB. The focus on a low-cost disposable test cartridge enhances its accessibility, making it suitable for use in various healthcare settings, including hospital emergency departments and international locations.

The testing capabilities of Proxim's device encompass a range of critical health conditions, including sepsis, cardiovascular diseases, and infectious diseases such as COVID-19 and influenza. Notably, the system includes tests for biomarkers like Procalcitonin (PCT), which is vital for differentiating bacterial infections in sepsis patients. The technology aims to improve patient outcomes by enabling rapid diagnosis and treatment, thereby reducing the risks associated with delayed medical intervention. Proxim's commitment to developing cost-effective and high-performance diagnostic solutions reflects its goal of enhancing healthcare delivery worldwide.

United States

Proxim Diagnostics - Next-generation point-of-care solution. COVID-19 antigen test.

Proxim Diagnostics

Company Details